Although contrast agents have an essential role in non-invasive imaging techniques, potential side effects limit their use. For example, both low- and iso-osmolar iodinated contrast media used in ...

ACA Pharma: [email protected] Azurity Pharmaceuticals: [email protected] ...

A new magnetic resonance imaging (MRI) contrast agent being tested by researchers at Case Western Reserve University not only pinpoints breast cancers at early stages but differentiates between ...

In a new pilot feasibility study, researchers from Mayo Clinic, the University of Washington School of Medicine, the ...

Researchers from the University of Washington School of Medicine in Seattle, Mayo Clinic in Rochester, Minn., the University ...

CHICAGO--(BUSINESS WIRE)--Ultrasound contrast agents show promise for detecting and evaluating uterine disorders and prostate cancers, scientists reported today at the annual Advances in Contrast ...

Las Vegas, NV / Syndication Cloud / January 23, 2026 / ContrastConnect The American College of Radiology (ACR) and the ...

The recommendation is included in the organization’s “Guidelines for the management of chronic coronary syndromes,” published Aug. 30 in the European Heart Journal. “Ultrasound contrast agents ...

Nanomedicine. 2015;10(2):321-341. Delivery: "Go where we want." The contrast agent must be able to be delivered in vivo and transported to the site of interest. Nontoxic: "Do no harm along the way." ...

BR55 was safe and highly accurate (>95%) at marking VEGFR2 expression in patients with breast, ovarian and thyroid cancer, as well as Crohn disease. The Food and Drug Administration (FDA) has granted ...

A new study has found why MRI scans may leave harmful metals behind in a person's body. The University of New Mexico (UNM) study explored health risks caused by toxic rare earth metal gadolinium, ...